Toggle navigation
About Us
Portfolio
News
Contact Us
Our venture capital fund focuses investments on early-stage life sciences companies looking to improve people’s outcomes with cancer.
Recent News
06/20/2023
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
READ MORE
06/06/2023
Q&A with John Mattick, PhD
READ MORE
05/31/2023
AI Proteins Announces the Formation of a Scientific Advisory Board Made up of Experts in Biotech and FDA Drug Approval
READ MORE
05/30/2023
C4 Therapeutics and Betta Pharmaceuticals Announce Exclusive Licensing Agreement for the Development and Commercialization in Greater China of CFT8919, an Orally Bioavailable BiDAC™ Degrader of EGFR L858R for NSCLC
READ MORE
←
1
3
4
5
6
7
8
9
10
11
...
53
→
PORTFOLIO HIGHLIGHTS
Contact Us
Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131
Submit
4837,4748,4815,4823,4811,4819,4822,4748,4772,4748,4789,4811,4830,4819,4815,4760,4792,4760,4791,4825,4828,4817,4811,4824,4778,4825,4831,4830,4822,4825,4825,4821,4760,4813,4825,4823,4748,4758,4748,4829,4831,4812,4820,4815,4813,4830,4748,4772,4748,4781,4825,4824,4830,4811,4813,4830,4746,4784,4825,4828,4823,4748,4839
©2021 LIGHTCHAIN CAPITAL, LLC All Rights Reserved |
Privacy Policy
Website by
Tidal Media Group